This is just price controls and fails for every other reason that price controls fails elsewhere. It puts the cost of drugs well above the market rate for such

This is just price controls and fails for every other reason that price controls fails elsewhere. It puts the cost of drugs well above the market rate for such drugs in that country and opens the door for local producers to simply undercut. The long term effect of is this is that US sellers will essentially become galapagos companies that only sell to the US and you effectively create two markets. The end state is exactly where we're at now but only with the US bearing even more of the cost.